Previous studies have demonstrated that inhibiting ferroptosis by modulating the expression of the circadian clock components Rev-erb-α/β and repurposing antioxidants as antiferroptotic agents exerts renal protective effects in experimental models of folic acid-induced AKI [33,34,35]. Here, CLOCK is linked to acute kidney injury.